Patch testing and cross sensitivity study of adverse cutaneous drug reactions due to anticonvulsants: A preliminary report

Figure 1 Attributes of 24 study patients for drug patch testing at a glance.

Figure 2 A patient of drug rash with eosinophilia and systemic symptoms from carbamazapine having prominently macular erythema and pruritic maculopapular rash over trunk (A) back, (B) front. She also had facial edema, conjuctival congestion and chemosis (not in picture); (C) Drug patch tests reactions (1+) reaction from carbamazepine (10%) and cross reactions (2+) from lamotrigine (10%, 20%, 30%), and (1+) from phenobarbitone (10%, 20%, 30%). Sodium valproate (10%, 20% and 30%) has elicited irritant reactions.